Clinical Trial Update: A Phase III Study of Jaktinib in Adults With Moderate and Severe Atopic Dermatitis [Phase 3]

View source ↗

Summary

Administrative update on a Phase III trial of jaktinib for adults with atopic dermatitis; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Jaktinib (jaktinib)

Snippet

Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd | Conditions: Atopic Dermatitis | Phase 3 | Status: ACTIVE_NOT_RECRUITING